Ran Mo

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Nano letters

Science advances

Nature communications

Biomaterials science

China Pharmaceutical University

China Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Pharmaceutical University

China

Professor :: Center of Advanced Pharmaceuticals and Biomaterials

University of North Carolina at Chapel Hill

United States

Postdoctoral Associate :: Joint Department of Biomedical Engineering

Education History

China Pharmaceutical University

China

PHD :: School of Pharmacy

Publications

Mingqi Liu, Yang Feng, Yougong Lu, Renqi Huang, Ying Zhang, Yanan Zhao, Ran Mo
Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy. Science advances 10 (11) (2024)
Yuqian Wang, Renqi Huang, Yougong Lu, Mingqi Liu, Ran Mo
Immuno-protective vesicle-crosslinked hydrogel for allogenic transplantation. Nature communications 15 (1) (2024)
Mingqi Liu, Yang Feng, Yougong Lu, Renqi Huang, Ying Zhang, Yanan Zhao, Ran Mo
Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy. Science advances 10 (11) (2024)
Yuqian Wang, Renqi Huang, Yougong Lu, Mingqi Liu, Ran Mo
Immuno-protective vesicle-crosslinked hydrogel for allogenic transplantation. Nature communications 15 (1) (2024)
Yuqian Wang, Renqi Huang, Yougong Lu, Mingqi Liu, Ran Mo
Immuno-protective vesicle-crosslinked hydrogel for allogenic transplantation. Nature communications 15 (1) (2024)
Huayu Liu, Mingqi Liu, Yanan Zhao, Ran Mo
Nanomedicine strategies to counteract cancer stemness and chemoresistance. Exploration of targeted anti-tumor therapy 4 (4) (2023)
Shiyang Shen, Shiqi Lin, Yuying Chen, Ying Zhang, Yingjiao He, Xiao Xu, Yang Feng, Yougong Lu, Ran Mo
Combating Cancer Stem-Like Cell-Derived Resistance to Anticancer Protein by Liposome-Mediated Acclimatization Strategy. Nano letters 22 (6) (2022)
He Dong, Xiaodan Hong, Yingjiao He, Zhengxiang Bao, Ying Zhang, Shiyang Shen, Guangji Wang, Jingwei Zhang, Ran Mo
A carrier-free metal-organic hybrid nanoassembly with combination anti-viral and hepato-protective activity for hepatitis B treatment. Biomaterials science 10 (15) (2022)
Shiyang Shen, Xiao Xu, Shiqi Lin, Ying Zhang, Huayu Liu, Can Zhang, Ran Mo
A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells. Nature nanotechnology 16 (1) (2021)
He Dong, Xiao Xu, Leikun Wang, Ran Mo
Advances in living cell-based anticancer therapeutics. Biomaterials science 8 (9) (2021)
Haojie Wang, Xiao Xu, Xin Guan, Shiyang Shen, Xuechao Huang, Guoyin Kai, Shunyi Zhao, Wenchen Ruan, Luyong Zhang, Tao Pang, Ran Mo
Liposomal 9-Aminoacridine for Treatment of Ischemic Stroke: From Drug Discovery to Drug Delivery. Nano letters 20 (3) (2020)
Xiao Xu, Xuechao Huang, Ying Zhang, Shiyang Shen, Zhizi Feng, He Dong, Can Zhang, Ran Mo
Self-regulated hirudin delivery for anticoagulant therapy. Science advances 6 (41) (2020)
Xiaojie Chen, Qiuwen Zhu, Xiao Xu, Shiyang Shen, Ying Zhang, Ran Mo
Sequentially Site-Specific Delivery of Apoptotic Protein and Tumor-Suppressor Gene for Combination Cancer Therapy. Small (Weinheim an der Bergstrasse, Germany) 15 (40) (2019)
Tianyue Jiang, Tong Wang, Teng Li, Yudi Ma, Shiyang Shen, Bingfang He, Ran Mo
Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma. ACS nano 12 (10) (2018)
Teng Li, Leikun Wang, Shiqi Lin, Xiao Xu, Meng Liu, Shiyang Shen, Zhengyu Yan, Ran Mo
Rational Design and Bioimaging Applications of Highly Specific "Turn-On" Fluorescent Probe for Hypochlorite. Bioconjugate chemistry 29 (8) (2018)
Shiyang Shen, Meng Liu, Teng Li, Shiqi Lin, Ran Mo
Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy. Biomaterials science 5 (8) (2018)
Meng Liu, Shiyang Shen, Di Wen, Mengru Li, Teng Li, Xiaojie Chen, Zhen Gu, Ran Mo
Hierarchical Nanoassemblies-Assisted Combinational Delivery of Cytotoxic Protein and Antibiotic for Cancer Treatment. Nano letters 18 (4) (2018)
Ding Qu, Lixiang Wang, Meng Liu, Shiyang Shen, Teng Li, Yuping Liu, Mengmeng Huang, Congyan Liu, Yan Chen, Ran Mo
Correction to Oral Nanomedicine Based on Multicomponent Microemulsions for Drug-Resistant Breast Cancer Treatment. Biomacromolecules 19 (3) (2018)
Tianyue Jiang, Shiyang Shen, Tong Wang, Mengru Li, Bingfang He, Ran Mo
A Substrate-Selective Enzyme-Catalysis Assembly Strategy for Oligopeptide Hydrogel-Assisted Combinatorial Protein Delivery. Nano letters 17 (12) (2017)
Ding Qu, Lixiang Wang, Meng Liu, Shiyang Shen, Teng Li, Yuping Liu, Mengmeng Huang, Congyan Liu, Yan Chen, Ran Mo
Oral Nanomedicine Based on Multicomponent Microemulsions for Drug-Resistant Breast Cancer Treatment. Biomacromolecules 18 (4) (2017)

Ran Mo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ran Mo